Selank Dosage: Dosing, and What It Means for Lean Mass

Selank dosage is an unusual case among research peptides, because a defined dose genuinely exists somewhere. This compound is a registered medicine in Russia, which means it has approved prescribing information: an indication, a route, a defined quantity and a duration, assessed by a regulator.

That makes the flat statement used for most research chemicals, that no dose has ever been established, inaccurate here. It is also nowhere near as helpful as it sounds, because the dose that exists belongs to a prescribed medicine used for a diagnosed condition under supervision, and that is not the situation of someone ordering a vial from a peptide vendor.

This article is about the distance between those two things, and about the second half of the title, where the honest answer is shorter.

What "a dose exists" actually means here

An approved dose is a package. It is tied to a specific indication, because dose is determined by what is being treated. It is tied to a specific formulation and route, because those determine how much reaches the site of action. It assumes the manufactured product the regulator assessed, not a chemically similar substance from another source. And it sits inside a clinical relationship where somebody is watching for response and for problems.

Detach the number from any part of that and it stops being the same number. A quantity that is appropriate for a patient with an anxiety disorder, using an approved preparation prescribed by a doctor, does not become appropriate for a healthy lifter using an unverified powder because the milligrams matched.

This is also why reproducing figures from foreign prescribing information is not a service. It launders a clinical decision into an internet instruction, and the safety framework that made the number meaningful does not travel with it.

Why Selank dosage figures online do not trace to that label

Circulating figures for this peptide come from several places, and the approved label is rarely one of them.

Vendor pages carry numbers that fit their vial sizes and match competitors. Forum practice accumulates as people copy each other and describe outcomes nobody measured. Numbers from the rat literature appear as if they scale, when rodent neurochemical studies chose doses to produce a measurable effect in a rat brain, which is not a translation to a person. And figures sometimes drift across from other peptides in the same catalogue, which is category confusion rather than pharmacology.

There is also a route mismatch that gets ignored. The registered Russian product is an intranasal preparation, and a great deal of the discussion online concerns injection. Route changes how much of a peptide reaches circulation and how quickly, so a number taken from one route and applied to another is not a conversion. It is a guess wearing the clothes of a calculation.

What is missing that a dose would need

Setting a dose for a purpose requires three things, and for the use most readers have in mind, none of them exists.

It requires an outcome to titrate against. For anxiety inside the Russian system that outcome is symptom improvement assessed by a clinician. For body composition there is no outcome at all, because no study in any organism has measured one.

It requires a known exposure, which means a pharmacokinetic dataset describing what the body does with the compound by the route in question. No such dataset is available in the Western literature for either route.

And it requires a safety boundary, an amount above which risk is understood to rise. Approved prescribing information contains one, for the approved product and the approved indication. There is no boundary for anything else, and none at all for an unverified research chemical.

Missing all three, a number is a preference rather than a dose.

The arithmetic people do instead

In practice the calculation runs backwards. A vial arrives with a stated quantity, a volume of solvent gets chosen because it makes the maths convenient, and the resulting figure is justified afterwards by whatever range the forums repeat.

Every step carries an unverified input. The stated quantity is the seller's claim. The concentration after reconstitution depends on that claim being accurate. Degradation during storage changes it again over time, at rates that depend on handling.

The output looks precise because it has decimal places. Precision arriving from arithmetic rather than from measurement is the most misleading number in the exercise, because it feels like control.

Two different products, compared honestly

Every row in the right hand column degrades the meaning of any number a person applies. That is the practical problem with dosing this compound outside Russia, and it is independent of what the molecule does.

The lean mass half of the title

There is no dose of this peptide for lean mass, and the reason is not that the right one has not been found. It is that no study in any organism has measured muscle mass, strength, power, body fat or muscle protein synthesis after administration. No dose response for a body composition endpoint exists because no body composition endpoint has ever been used.

The mechanistic literature confirms the direction of the research rather than contradicting it. Rat studies have reported effects on brain serotonin metabolism and on brain derived neurotrophic factor expression. Work in human plasma has described slowed breakdown of endogenous enkephalins. This is the neurochemistry of an anxiolytic. Nothing in it touches the myostatin pathway or anabolic signalling in any species.

Two claims get merged here and should be separated. One is that reducing anxiety could help someone train more consistently, which is a plausible behavioural chain. The other is that the compound acts on tissue, which nothing in the literature supports in any species. Only the first is even arguable, and a dose cannot be set against a behavioural chain no study has measured.

The indirect argument, that reduced anxiety could protect sleep and training consistency and that consistency protects lean mass over decades, is coherent as reasoning. It has never been tested for this compound. No study has followed people using it and measured training adherence, recovery or composition, so a dose cannot be set for an effect nobody has demonstrated.

What remains unknown outside a clinic

No genuine Western trial of this peptide has ever been registered. Searches of Western registries return records that mention the term while studying something else: an epilepsy drug, transcranial stimulation for dyslexia, telephone psychotherapy for depression, neurofeedback training, balance exercises. Counting those hits is how false trial counts get published, and reading the titles removes all of them.

So there is no dose finding study a Western reader can check, no published pharmacokinetic dataset to reason from, and no safety profile collected under a system whose standards they know. What exists is real clinical experience inside one country's medical system, and complete absence from the evidence system most readers implicitly rely on. Both halves are true and neither substitutes for the other.

Questions this raises